| Literature DB >> 34716675 |
Sara Morassaei1,2, Lisa Di Prospero1,3, Elisabeth Ringdalen4, Sunniva S Olsen4, Agnethe Korsell4, Darby Erler5, Carmen Ying6, Sang Ho Choi6, Amanda Bolderston6, Jacqueline Middleton6, Safora Johansen4,7.
Abstract
INTRODUCTION: Several studies have demonstrated the psychological impact of the COVID-19 pandemic on health care providers. However, there is little known about how the COVID-19 pandemic has impacted radiation therapists (RTs) in Norway or Canada. The aim of this investigation was to study the psychological impact of working during the COVID-19 pandemic among RTs in Canada and Norway.Entities:
Keywords: Coronavirus; anxiety; health personnel; mental health; psychological stress; quality of life; radiotherapy
Mesh:
Year: 2021 PMID: 34716675 PMCID: PMC8656195 DOI: 10.1002/jmrs.557
Source DB: PubMed Journal: J Med Radiat Sci ISSN: 2051-3895
Questions from survey administered to RTs in Canada and Norway.
|
|
|
|---|---|
| Demographics |
Are you a Canadian/Norwegian radiation therapist currently working in a Canadian/Norwegian radiation therapy department? If yes, were you working as a radiation therapist before October 1, 2019? Are you a radiation therapy manager? If yes, link to the survey for RT managers (Table What is your radiation therapy role? What is your age? What is your gender? What province/county do you work in? Since March 2020, have you been working full‐time or part‐time? What are your years of working experience in radiation therapy? What is your level of education? |
| Work‐related stressors due to COVID‐19 |
Which of the following factors, if any, are impacting you psychologically? Changes in staffing due to COVID‐19 Changes in patient volumes due to COVID‐19 Changes in PPE usage due to COVID‐19 Changes in household income due to COVID‐19 Fear of transmitting COVID‐19 into workplace Fear of transmitting COVID‐19 from work to family and friends Fear of acquiring COVID‐19 from work |
| Work‐related psychological impact due to COVID‐19 |
I have experienced work‐related stress due to COVID‐19 (on a scale of 1–5). I have experienced work‐related anxiety due to COVID‐19 (on a scale of 1–5). I have experienced work‐related depression due to COVID‐19 (on a scale of 1–5). I have experienced work‐related insomnia due to COVID‐19 (on a scale of 1–5). Are there any other mental health issues that you are experiencing due to working in a COVID‐19 environment? Do you feel that the psychological impact of the COVID‐19 pandemic has affected your quality of life? |
| Availability and use of support programmes at the workplace |
In my workplace, there are support programmes for dealing with psychological issues due to COVID‐19. I have accessed workplace support programmes for dealing with psychological issues due to COVID‐19. Are there any other forms of support you are using to deal with psychological issues due to COVID‐19? |
Questions from survey administered to RT department managers in Canada and Norway.
|
|
|
|---|---|
| Departmental changes |
Please indicate which measures were implemented for patients on treatment to reduce the risk of the COVID‐19 pandemic. Please indicate which treatment related or departmental policy changes were implemented due to the COVID‐19 pandemic. |
| Patient volume |
How did the patient volume in your department change during the first wave (March to May 2020) of the COVID‐19 pandemic? How did the patient volume in your department change during the second wave (since October 2020 to present) of the COVID‐19 pandemic? |
| Staff shortages and redeployment |
Were there any staff shortages in your department during the first wave (March‐May 2020) of the COVID‐19 pandemic? If yes, please specify the reasons for the staff shortages. If yes, how has the shortage of staff been addressed? (Please specify) Were there any staff shortages in your department during the second wave (October* 2020) of the COVID‐19 pandemic? If yes, please specify the reasons for the staff shortages. If yes, how has the shortage of staff been addressed? (Please specify) Did you have staff redeployed during the COVID‐19 pandemic? |
| PPE and infection control measures |
Has training in the correct use of PPE in relation to COVID‐19 and infection control training been provided to all staff? (PPE = e.g., medical masks, eye protection, disposable gowns, etc.) Are there clear PPE guidelines established in your department? Do you feel that your employees have been affected by the infection control measures that have been implemented in your department due to the COVID‐19 pandemic? |
Location of Norwegian and Canadian RT survey respondents.
|
|
|
|---|---|
|
| |
| Agder | 6 |
| Innlandet & Trondelag | 6 |
| Møre og Romsdal | 8 |
| Nordland & Troms og Finnmark | 9 |
| Oslo | 48 |
| Rogaland | 6 |
| Vestland | 17 |
|
| |
| Alberta | 27 |
| British Columbia | 21 |
| Nova Scotia & New Brunswick | 11 |
| Ontario | 36 |
| Quebec | 4 |
Some counties and provinces were merged due to the small number of respondents from these locations.
Demographic characteristics, presence of work‐related stressors due to COVID‐19, and psychological impact due to COVID‐19 reported by Norwegian and Canadian RTs.
|
|
|
|
|---|---|---|
|
|
| |
|
| ||
| <30 years | 12 | 22 |
| 30–39 years | 32 | 39 |
| 40–49 years | 28 | 23 |
| 50+ years | 25 | 17 |
| Prefer not to say | 2 | – |
|
| ||
| Male | 19 | 15 |
| Female | 79 | 83 |
| Prefer not to say | 2 | 3 |
|
| ||
| Full‐time | 82 | 80 |
| Part‐time | 18 | 20 |
|
| ||
| 0–5 | 15 | 27 |
| 6–10 | 22 | 19 |
| 11–15 | 16 | 18 |
| 16–20 | 20 | 12 |
| 21–25 | 13 | 15 |
| 25+ | 14 | 9 |
|
| ||
| Diploma | – | 10 |
| Bachelor’s degree | 95 | 77 |
| Master’s degree or higher | 5 | 12 |
| Prefer not to say | – | 1 |
|
| ||
| Pre‐treatment and dosimetry | 41 | 13 |
| Treatment therapist | 39 | 68 |
| Educator | 11 | 5 |
| Other | 9 | 15 |
|
| ||
| Changes in staffing due to COVID‐19 | 40 | 41 |
| Changes in patient volumes due to COVID‐19 | 13 | 21 |
| Changes in PPE usage due to COVID‐19 | 29 | 59* |
| Changes in household income due to COVID‐19 | – | 20 |
| Fear of transmitting COVID‐19 into workplace | 68 | 52* |
| Fear of transmitting COVID‐19 from work to family/friends | 57 | 76* |
| Acquiring COVID‐19 from work | 34 | 59* |
Chi‐square significant differences for categorical variables and independent sample t‐test for significant mean differences between Canadian and Norwegian respondents, *P < 0.05.
Value is suppressed due to small cell count.
Themes and representative quotations from the free‐text answers given by Norwegian and Canadian RTs.
|
|
|
|
|---|---|---|
|
| 1. Generalised anxiety |
|
| 2. Physical, emotional, & cognitive symptoms of stress |
| |
| 3. Loneliness |
| |
|
| 1. Negatively impacted physical and mental health |
|
| 2. Quality of relationships |
|
Adjusted odds ratios (OR) and 95% confidence intervals (CI) for the probability of reporting negative impact on quality of life (QOL) by demographics and presence of work‐related stressor due to COVID‐19 among Norwegian and Canadian RTs.
|
|
| |||
|---|---|---|---|---|
|
|
| |||
|
|
|
|
| |
|
| ||||
| <30 years | 0.19 | (0.01–3.19) | 0.13 | (0.01–4.27) |
| 30–39 years | 1.53 | (0.24–9.87) | 0.61 | (0.03–12.48) |
| 40–49 years | 2.60 | (0.48–14.23) | 0.27 | (0.03–2.94) |
| 50+ years |
|
| ||
|
| ||||
| Male |
|
| ||
| Female | 0.45 | (0.13–1.55) |
|
|
|
| ||||
| Full‐time |
|
| ||
| Part‐time | 1.13 | (0.34–3.81) | 0.55 | (0.14–2.12) |
|
| ||||
| 0–5 |
|
| ||
| 6–10 | 0.84 | (0.11–6.42) |
|
|
| 11–15 | 0.70 | (0.08–6.39) | 0.58 | (0.05–6.76) |
| 16–20 | 0.65 | (0.05–8.60) | 0.55 | (0.03–9.12) |
| 21–25 | 0.53 | (0.04–7.29) | 0.96 | (0.05–18.83) |
| 25+ | 1.51 | (0.10–24.17) | 0.25 | (0.01–9.29) |
|
| ||||
| Diploma | – | – | 0.21 | (0.01–4.96) |
| Bachelor’s degree |
| 0.14 | (0.01–2.04) | |
| Master’s degree or higher | 0.17 | (0.01–2.70) |
| |
|
| ||||
| Pre‐treatment and Dosimetry | 0.79 | (0.25–2.50) | 1.31 | (0.22–7.92) |
| Treatment Therapist |
|
| ||
| Educator | 1.20 | (0.23–6.18) | 0.12 | (0.01–1.65) |
| Other | 0.71 | (0.14–3.70) | 3.04 | (0.54–17.20) |
|
| ||||
| Changes in staffing due to COVID‐19 | 2.57 | (0.93–7.07) |
|
|
| Changes in patient volumes due to COVID‐19 | 1.30 | (0.29–5.77) | 2.94 | (0.59–14.69) |
| Changes in PPE usage due to COVID‐19 |
|
| 0.76 | (0.28–2.06) |
| Transmitting COVID‐19 into workplace | 1.53 | (0.46–5.05) | 1.24 | (0.38–4.04) |
| Transmitting COVID‐19 from work to family/friends | 0.85 | (0.24–3.04) | 2.06 | (0.53–8.11) |
| Acquiring COVID‐19 from work | 0.88 | (0.27–2.84) | 1.12 | (0.34–3.68) |
Bolding indicates significant associations, P < 0.05.
The reference category used for each association is provided in the table using ‘ref’.
Models are fully adjusted for all other variables in table. Reported changes in household income are not included due to small cell counts.